Xcout IntelSign inSubscribe

PHCホールディングス competitors & alternatives

6523HealthtechTokyo, Japan

The 12 closest competitors and alternatives to PHCホールディングス among healthtech companies — ranked by similarity to what PHCホールディングス actually does, not by market-cap band.

$1.1BMarket cap
8,647Employees
12Competitors listed

Subscribe to see PHCホールディングス’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About PHCホールディングス

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.

PHCホールディングス at a glance

PHCホールディングス is a healthtech company headquartered in Tokyo, Japan. It is publicly listed (6523) with a market capitalisation of $1.1B. Xcout tracks 20 named people at PHCホールディングス, including Kyoko Deguchi (President, Representative Director, Chairman of Board).

PHCホールディングス leadership

  • Kyoko DeguchiPresident, Representative Director, Chairman of Board
  • Koichiro SatoSenior Executive Vice President, Representative Director
  • Kaiju YamaguchiSenior Executive Corporate Officer Chief Financial Officer (CFO)
  • Ryuichi HirashimaSenior Executive Corporate Officer Chief Administrative Officer (CAO) Chief Human Resources Officer (CHRO) Chief Technology Officer (CTO)
  • Chikara TakauoCorporate Officer
  • Hideaki TakahashiCorporate Officer

14 more named people on record for PHCホールディングス, with roles, board committees and tenure — see the full roster →

Recent PHCホールディングス news

Top 12 PHCホールディングス competitors

Ranked by semantic similarity — how close each company is to PHCホールディングス by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

CELLBXHEALTH PLCCLBX · BiotechGuildford, United Kingdom
66% matchPublic

Biotech

CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.

Market cap$20.4M
Employees119
CELLBXHEALTH PLC competitors & alternatives →
大塚ホールディングス4578 · PharmaceuticalsTokyo, Japan
65% matchPublic

Pharmaceuticals

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Market cap$35.6B
Employees37,758
大塚ホールディングス competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of PHCホールディングス and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for PHCホールディングスand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →